Urodynamic profile in the Department of Urology, Cipto Mangunkusumo Hospital Between 2010 and 2015
BACKGROUND This study was aimed to describe urodynamic profiles, the role and advantages of urodynamics for urinary problems detection, and to analyze whether urodynamic examination has been ordered based on accurate indications following guidelines in the Department of Urology Cipto Mangunkusumo Hospital between 2010 and 2015.
METHODS Data was retrieved from the patient’s medical records who underwent urodynamic examinations in the Department of Urology Cipto Mangunkusumo Hospital between July 2010 to August 2015.
RESULTS 1,091 patients undergone urodynamic procedures in the Department of Urology Cipto Mangunkusumo Hospital. In 553 lower urinary tract symptoms (LUTS) patients, there were 186 (34%) small bladder capacity, 84 (15%) detrusor overactivity (DO), 180 (33%) bladder outlet obstruction (BOO), and 198 (36%) bladder atony patients. In the 317 urinary retention patients, there were 121 (38%) patients with BOO and 2 (1%) patients with a normal voiding phase. In 80 overactive bladder patients, there were 51 (64%) with DO, 17 (21%) with DO incontinence, and 22 (28%) with urodynamic stress incontinence (SI). Among 81 patients with SI problems, there were 63 (78%) urodynamic SI, 9 (11%) DO, and 9 (11%) DO incontinence patients. In 60 (6%) pediatric patients, most LUTS and urinary retention patients were caused by impaired bladder contraction.
CONCLUSIONS This study shows the role and superiority of urodynamics in diagnosing patients with voiding disorders, especially if with mixed components in it. Urodynamics played essential roles in detecting urinary problems at Cipto Mangunkusumo Hospital.
Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int. 2003;92(4):409-14. https://doi.org/10.1046/j.1464-410X.2003.04369.x
Nitti VW. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005;7(Suppl 6):S14-21.
Javlé P, Jenkins SA, Machin DG, Parsons KF. Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy. J Urol. 1998;160(5):1713-7. https://doi.org/10.1016/S0022-5347(01)62391-7
Gravas S, Bachmann A, Descazeaud A, Drake M, Gratzke C, Madersbacher S, et al. Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). European Association of Urology [online], 2015.
Hardjowijoto S, Taher A, Poernomo B, Umbas R, Sugandi S, Rahardjo D. Pedoman penatalaksanaan BPH di Indonesia. Surabaya: IAUI, 2015.
Abrams P, Cardozo L, Khoury S, Wein A. Incontinence: 5th International Consultation on Incontinence, Paris, February 2012. ICUD-EAU, 2013.
Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50(6):1306-14. https://doi.org/10.1016/j.eururo.2006.09.019
Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327-36.
Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee. An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 2005;96(9):1314-8. https://doi.org/10.1111/j.1464-410X.2005.05835.x
Malmsten UG, Milsom I, Molander U, Norlén LJ. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol. 1997;158(5):1733-7. https://doi.org/10.1016/S0022-5347(01)64113-2
Engström G, Walker-Engström ML, Lööf L, Leppert J. Prevalence of three lower urinary tract symptoms in men-a population-based study. Fam Pract. 2003;20(1):7-10. https://doi.org/10.1093/fampra/20.1.7
Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230-7. https://doi.org/10.1002/nau.22295
Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760-6. https://doi.org/10.1046/j.1464-410x.2001.02228.x
Tirtayasa PM, Rahardjo HE. A survey on the management of overactive bladder by Indonesian urologists. Med J Indones. 2015;24(2):91-6. https://doi.org/10.13181/mji.v24i2.1172
Rahardjo HE, Santoso BI, Hakim S, Hasan B, Tjahjodjati, Moegni F. Inkontinensia urin pada usia lanjut. In: Rahardjo HE. Panduan tata laksana inkontinensia urin pada dewasa. Jakarta: Perkumpulan Kontinensia Indonesia (PERKINA). 2018;36-55.
González Ruiz MI, Flores Carreras O, Velázquez Castellanos PI, Martínez Espinoza CJ, Márquez Allegre R, Aquino Hernández JL. "[Prevalence and clinical-urodynamic characteristics of vesical voiding dysfunction in two urodynamic centres]." Ginecol Obstet Mex. 2005;73(11):596-603.
Rademakers KL, van Koeveringe GA, Oelke M. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate. Curr Opin Urol. 2016;26(1):3-10. https://doi.org/10.1097/MOU.0000000000000246
Fan YH, Lin CC, Lin AT, Chen KK. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity? J Chin Med Assoc. 2011;74(10):455-9. https://doi.org/10.1016/j.jcma.2011.08.016
Al-Ghazo MA, Ghalayini IF, Al-Azab R, Hani OB, Matani YS, Haddad Y, et al. Urodynamic detrusor overactivity in patients with overactive bladder symptoms. Int Neurourol J. 2011;15(1):48-54. https://doi.org/10.5213/inj.2011.15.1.48
Colli E, Artibani W, Goka J, Parazzini F, Wein AJ. Are urodynamic tests useful tools for the initial conservative management of non-neurogenic urinary incontinence? a review of the literature. Eur Urol. 2003;43(1):63-9. https://doi.org/10.1016/S0302-2838(02)00494-3
Aditya S, Mathur SK. Mirabegron: a first-in-class beta-3 agonist for overactive bladder. J Mahatma Gandhi Inst Med Sci. 2015;20(2):128-33. https://doi.org/10.4103/0971-9903.164227
Szabó L, Lombay B, Borbás E, Bajusz I. Videourodynamics in the diagnosis of urinary tract abnormalities in a single center. Pediatr Nephrol. 2004;19(3):326-331. https://doi.org/10.1007/s00467-003-1341-8
Copyright (c) 2019 Angling Yunanto, Harrina Erlianti Rahardjo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.